Ser302
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser302  -  hnRNP K (mouse)

Site Information
GrGGrGGsrARNLPL   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 457408

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 2 ) , phospho-antibody ( 1 , 2 ) , western blotting ( 1 , 2 )
Disease tissue studied:
diabetes mellitus ( 1 ) , type 2 diabetes ( 1 )
Relevant cell line - cell type - tissue:
kidney ( 1 ) , MCT cells (epithelial) ( 1 , 2 )

Upstream Regulation
Putative in vivo kinases:
PKCD (mouse) ( 1 )
Treatments:
angiotensin_2 ( 2 ) , PP2 ( 2 )

Downstream Regulation
Effects of modification on hnRNP K:
molecular association, regulation ( 2 )
Effects of modification on biological processes:
translation, induced ( 2 )
Induce interaction with:
RNA ( 2 )

References 

1

Sataranatarajan K, Lee MJ, Mariappan MM, Feliers D (2008) PKCdelta regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K. Cell Signal 20, 969-77
18295448   Curated Info

2

Feliers D, et al. (2007) Heterogeneous nuclear ribonucleoprotein K contributes to angiotensin II stimulation of vascular endothelial growth factor mRNA translation. Am J Physiol Renal Physiol 293, F607-15
17581920   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2024 Cell Signaling Technology, Inc.